DEWIDAR, O., T. LOTFI, M. W. LANGENDAM, E. PARMELLI, Z. SAZ PARKINSON, K. SOLO, D. K. CHU, J. L. MATHEW, E. A. AKL, R. BRIGNARDELLO-PETERSEN, R. A. MUSTAFA, L. MOJA, A. IORIO, Y. CHI, C. CANELO-AYBAR, T. KREDO, J. KARPUSHEFF, A. F. TURGEON, P. ALONSO-COELLO, W. WIERCIOCH, A. GERRITSEN, Miloslav KLUGAR, M. X. ROJAS, P. TUGWELL, V. A. WELCH, K. POTTIE, Z. MUNN, R. NIEUWLAAT, N. FORD, A. STEVENS, J. KHABSA, Z. NASIR, G. LEONTIADIS, J. MEERPOHL, T. PIGGOTT, A. QASEEM, M. MATTHEWS a H. J. SCHÜNEMANN. Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance. BMJ EVIDENCE-BASED MEDICINE. London: BMJ PUBLISHING GROUP, roč. 28, č. 3, s. 189-196. ISSN 2515-446X. doi:10.1136/bmjebm-2022-111962. 2023.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance
Autoři DEWIDAR, O., T. LOTFI, M. W. LANGENDAM, E. PARMELLI, Z. SAZ PARKINSON, K. SOLO, D. K. CHU, J. L. MATHEW, E. A. AKL, R. BRIGNARDELLO-PETERSEN, R. A. MUSTAFA, L. MOJA, A. IORIO, Y. CHI, C. CANELO-AYBAR, T. KREDO, J. KARPUSHEFF, A. F. TURGEON, P. ALONSO-COELLO, W. WIERCIOCH, A. GERRITSEN, Miloslav KLUGAR (203 Česká republika, domácí), M. X. ROJAS, P. TUGWELL, V. A. WELCH, K. POTTIE, Z. MUNN, R. NIEUWLAAT, N. FORD, A. STEVENS, J. KHABSA, Z. NASIR, G. LEONTIADIS, J. MEERPOHL, T. PIGGOTT, A. QASEEM, M. MATTHEWS a H. J. SCHÜNEMANN (garant).
Vydání BMJ EVIDENCE-BASED MEDICINE, London, BMJ PUBLISHING GROUP, 2023, 2515-446X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30230 Other clinical medicine subjects
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.800 v roce 2022
Kód RIV RIV/00216224:14110/23:00129963
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1136/bmjebm-2022-111962
UT WoS 000783805700001
Klíčová slova anglicky COVID-19; Evidence-Based Practice
Štítky 14119612, 14119613, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 26. 1. 2024 09:54.
Anotace
An evidence-based approach is considered the gold standard for health decision-making. Sometimes, a guideline panel might judge the certainty that the desirable effects of an intervention clearly outweigh its undesirable effects as high, but the body of supportive evidence is indirect. In such cases, the application of the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach for grading the strength of recommendations is inappropriate. Instead, the GRADE Working Group has recommended developing ungraded best or good practice statement (GPS) and developed guidance under which circumsances they would be appropriate.Through an evaluation of COVID-1- related recommendations on the eCOVID Recommendation Map (COVID-19.recmap.org), we found that recommendations qualifying a GPS were widespread. However, guideline developers failed to label them as GPS or transparently report justifications for their development. We identified ways to improve and facilitate the operationalisation and implementation of the GRADE guidance for GPS.Herein, we propose a structured process for the development of GPSs that includes applying a sequential order for the GRADE guidance for developing GPS. This operationalisation considers relevant evidence-to-decision criteria when assessing the net consequences of implementing the statement, and reporting information supporting judgments for each criterion. We also propose a standardised table to facilitate the identification of GPS and reporting of their development. This operationalised guidance, if endorsed by guideline developers, may palliate some of the shortcomings identified. Our proposal may also inform future updates of the GRADE guidance for GPS.
VytisknoutZobrazeno: 16. 4. 2024 22:33